Mechanisms Regulating Cuproplasia

Unlike metabolites, metals cannot be created or destroyed. Therefore, maintaining metal homeostasis through precise regulation of uptake, trafficking, and efflux pathways is critical for cellular function. This is especially true for highly reactive transition metals like copper, where even slight imbalances can have significant consequences. Copper-regulated fitness impairments (cuproplasia) can occur through different genetic and environmental  mechanisms. In our lab, we previously identified and characterized a new form of regulated cell death, termed “cuproptosis,” caused by mitochondrial copper accumulation. Building on this discovery, our current research aims to uncover additional mechanisms driving cuproplasia through chemical genomic approaches.
Key questions guiding our work include:: (i) What are the genes and mechanisms involved in copper trafficking (transporters and chaperones), intracellular distribution (specific organelle compartmentalization), and toxicity (cell death mechanisms)? (ii) What are the common and shared stress response pathways associated with cuproplasia? (iii) How do signaling, metabolic, or viability-regulating networks respond to metal availability to promote cellular fitness?
By addressing these questions, we aim to provide a comprehensive understanding of copper’s role in cellular physiology and its potential as a therapeutic target in diseases driven by metal imbalances.

Research Overview of the Tsvetkov Lab

Mechanisms Regulating Protein Lipoylation in Health and Disease

Protein lipoylation is a lipid post-translational modification that occurs on conserved lysine residues of four key mitochondrial metabolic complexes. This modification is essential for the enzymatic function of these complexes, which include pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH), branched-chain α-ketoacid dehydrogenase (BCKDH), and glycine decarboxylase complex (GDC), also known as the glycine cleavage system. Despite its critical role in cellular metabolism and the remarkable conservation of this pathway from bacteria to humans, little is known about the mechanisms regulating lipoylation or its involvement in human disease.

At the Tsvetkov Lab, we aim to uncover the fundamental principles governing lipoylation regulation in human cells and explore how lipoylation defects influence viability and tumor progression. Additionally, we are developing innovative molecular tools to enhance lipoylation in cells, offering potential therapeutic strategies for diseases where lipoylation deficiencies are detrimental.